Platelet Rich Fibrin is one of 110 biologic programs targeting Pain. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
51 competitors in ESS
Lexapro
Proamatine
Quviviq
Darzalex
Platelet Rich Fibrin
Decadron
Revlimid
Kyprolis
Mineral Trioxide Aggregate
Ritalin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details